In Vitro Skin Models and Their Predictability in Defining Normal and Disease Biology, Pharmacology, and Toxicity
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
In vitro skin model systems are increasingly being used both in the early evaluation of therapeutic drug candidates and in confirmatory mechanistic studies. The most commonly used of these in vitro model systems are reconstituted human epidermis (RHE) models. These RHE models consist solely of epidermal keratinocytes, which comes with some limitations but also with the advantage of focusing toxicologic and pharmacologic evaluation on keratinocytes alone. RHE models can generally be implemented more quickly, easily, and reproducibly than in vivo models and can thus be used for high throughput compound screening while potentially reducing the need for animal studies. Histologic evaluation of RHE sections can be done quite easily, and the sections are very amenable to quantification via image analysis, including automated analysis. RHE model systems can provide very valuable early indications of therapeutic candidate biology, pharmacology, and toxicity; and early results have demonstrated that RHE models have been quite predictive for in vivo pharmacologic and toxicologic effects on the skin, including clinical skin toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boniface, K., Bernard, F.-X., Garcia, M., Gurney, A. L., Lecron, J.-C., & Morel, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3695 · Cited by 864
Sano, S., Chan, K. S., Carbajal, S., Clifford, J., Peavey, M., Kiguchi, K., Itami, S., Nickoloff, B. J., & DiGiovanni, J. (2005) · Nature Medicine · doi:10.1038/nm1162 · Cited by 752 · cited 2×
“Some of the morphologic and differentiation features that IL-22 induced in RHE, such as hyperplasia and hypogranulosis (Figure 5A), upregulation of the expression of the hyperproliferative cytokeratin 6 (Figure 5B) and the antimicrobial peptide S100A7 (Figure 5C), and activation/phosphorylation of the nuclear transcri…”
BackgroundDiegel, K. L., Danilenko, D. M., & Wojcinski, Z. W. (2013) · Haschek and Rousseaux's Handbook of Toxicologic Pathology · doi:10.1016/b978-0-12-415759-0.00055-8 · Cited by 6
Self-citation
Cited by
Hardwick, R. N., Betts, C. J., Whritenour, J., Sura, R., Thamsen, M., Kaufman, E. H., & Fabre, K. (2020) · Lab on a Chip · doi:10.1039/c9lc00519f · Cited by 48
Ferrous iron–activatable drug conjugate achieves potent MAPK blockade in KRAS -driven tumors
Jiang, H., Muir, R. K., Gonciarz, R. L., Olshen, A. B., Yeh, I., Hann, B. C., Zhao, N., Wang, Y.-H., Behr, S. C., Korkola, J. E., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20210739 · Cited by 33
“S2 A), confirming the conserved, essential role for MEK1/2 in the cellular epidermal layer (Azan et al., 2017; Danilenko et al., 2016).”
Modeling of solar UV-induced photodamage on the hair follicles in human skin organoids
Kim, M.-J., Ahn, H.-J., Kong, D., Lee, S., Kim, D.-H., & Kang, K.-S. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241248753 · Cited by 25
Portugal-Cohen, M., Cohen, D., Kohen, R., & Oron, M. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1215266 · Cited by 24
“ASM, based on human cells, reconstructed skin, ex vivo skin, organ-on-a-chip, and computational in silico models, have emerged as a promising solution, as they are more cost-effective and sustainable, present fewer ethical considerations, and, in certain cases, show advantages compared to the corresponding animal mode…”
BackgroundAssessment of Skin Toxicity in an in Vitro Reconstituted Human Epidermis Model Using Deep Learning
Hu, F., Santagostino, S. F., Danilenko, D. M., Tseng, M., Brumm, J., Zehnder, P., & Wu, K. C. (2022) · The American Journal of Pathology · doi:10.1016/j.ajpath.2021.12.007 · Cited by 13
Self-citation
Metadata
- Authors
- Danilenko, D. M., Phillips, G. D. L., & Diaz, D.
- Venue
- Toxicologic Pathology
- Publisher
- SAGE Publications
- Published
- 2016-03-02
- Volume
- 44
- Issue
- 4
- Pages
- 555-563
- ISSN
- 0192-6233 (ISSN-L)
- 1533-1601
- OpenAlex
- W2291170163
- Cited by
- 40
- References
- 3
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.